RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @CarlaFisherMD: Agreed. Most. We should not be committing ALL patient with 1-3+ nodes to PMRT. https://t.co/fxumVxaf11
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
Interesting study. Certainly hypothesis generating. https://t.co/XklECFGC8t
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
RT @danielzliu: #BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https:/…
#BreastCancer patients with T2-1N1 tumors do not need #radiation routinely, with similar low local recurrence rates https://t.co/PwVnMy2o00 https://t.co/fDpH7M5tjZ
RT @therealmiral: Axilla : so many options .. Radiate or not Radiate..? Dissect or not to dissect .. ? Do both ..? Do none ? Interestin…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
Axilla : so many options .. Radiate or not Radiate..? Dissect or not to dissect .. ? Do both ..? Do none ? Interesting article to add to the debate .. @ASBrS https://t.co/QvLbTB0pWd
We keep going back and forth on this issue https://t.co/hGdzkzUnX3
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT SocSurgOnc RT AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmastectomy Radiotherapy.https://t.co/7RJEP9hXP8
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmastectomy Radiotherapy. https://t.co/iLO65m1aOD https://t.co/iLO65m1aOD
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @CarlaFisherMD: Agreed. Most. We should not be committing ALL patient with 1-3+ nodes to PMRT. https://t.co/fxumVxaf11
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
Agreed. Most. We should not be committing ALL patient with 1-3+ nodes to PMRT. https://t.co/fxumVxaf11
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
RT @AnnSurgOncol: AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmaste…
AHEAD OF PRINT: Most #BreastCancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need #Postmastectomy Radiotherapy.https://t.co/uSbnPCGxnv